At Taiwan-based TMU x BE accelerator’s demo day on July 20, startups discussed their solutions, which tackle topics like Digital Health, Medical Devices and AI Healthcare.
A series of startups told their stories as part of TMU x BE Accelerator’s demo day.
Further, TMU BioMed Accelerator is Taiwan’s first international medical university accelerator with a perfect medical marketplace, clinical advantages, biomedical and AI talents, focusing on digital health, artificial intelligence and medical equipment.
And BE Accelerator is the largest growth-focused program and venture fund for healthtech, medtech and digital health startups in Taiwan. Started in 2018, BE backed fifty-one healthcare entrepreneurs, and raise $75.8M+ USD successfully.
Demo day Live: https://reurl.cc/W3RGQk
Here’s a peek at the companies that presented during the July 20 demo day:
UpperMed, a Singapore-based MedTech company which is working on home dialysis remote management service. The team is dedicated to improving the quality of life for dialysis patients.
Based in Singapore, Meracle wants to improve the management of chronic respiratory diseases by increasing the efficiency of medication delivered into the lungs while tracking intake data to optimize the assessment of treatment outcomes.
With a team of data scientists with a single-minded focus on driving innovative computing in clinical genomics, Atgenomix accelerates future life science and helps overwhelmed researchers and clinicians deal with the immense challenges of data deluge in genomics.
SiriuXense builds the “Smart Care Ecosystem for All Ages” by integrating bioacoustics sensing technology, algorithm, IoT, and a data-driven platform.
Based in Taiwan, LuminX is a pharmacokinetic platform for preclinical evaluation of therapeutic cells to transform a potential therapy from the research stage to advanced clinical and commercial applications to save lives.
ezOxygen Spirometer utilizes exclusive passive ultrasonic detection technology to record the sound from the user’s exhalation, transmit to the mobile app and calculate as lung function parameters, provide user managing their own lung health status.
B.D.Mobile is a medical technology company committed to making cardiac diagnostics scalable and accessible to everyone, by creating solutions for clinicians to face the ever-increasing demand for diagnostics.
PROPHET, an AI Bio-maker model using AI technology to screen cancer and provide the prediction.
Focuses on long-term healthcare, HomeXin provides hospitalized families comprehensive help services.
Last but not least, TMU BioMed and BE accelerator’s 2021 Market Expansion Pilot Trial allows startups to expand in American and Japanese markets to activate their growth after the demo day.
About TMU BioMed Accelerator
Taiwan’s first international medical university accelerator with a perfect medical marketplace, clinical advantages, biomedical and artificial intelligence talents, focusing on digital health, artificial intelligence and medical equipment, assisting start-up to raise funds, community and international resource linkage, coaching and reducing development risks, clinical trial planning, establishing medical pathways.
About BE Accelerator
BE Accelerator is the largest growth-focused program and venture fund for healthtech, medtech and digital health startups in Taiwan. Based in Taipei, we leverage the unique strengths of our thriving ecosystem to position as the gateway to Asia for both local and international startups. Started in 2018, we back fifty-one healthcare entrepreneurs, and raise $75.8M+ USD successfully.